Key result
Carvedilol lowers blood pressure by decreasing vascular resistance and offers a more favorable metabolic profile than conventional beta-blockers.
Why the study?
Does carvedilol improve hemodynamic and metabolic profiles compared to conventional beta-blockers in patients with hypertension?
Population
Patients with hypertension
Comparison
Carvedilol vs Conventional beta-blockers
Design
Review
Authors
Loading...
May support carvedilol consideration in hypertension; leaves open effects on morbidity and mortality versus older agents.
Does carvedilol improve hemodynamic and metabolic profiles compared to conventional beta-blockers in patients with hypertension?
Carvedilol, a vasodilating beta-blocker, provides effective blood pressure reduction without the adverse metabolic and hemodynamic effects of traditional beta-blockers, making it a potentially valuable option for hypertension management.
Panagiotis Stafylas (2008) conducted a review in Hypertension. Carvedilol vs. Conventional beta-blockers was evaluated. Carvedilol lowers blood pressure by decreasing vascular resistance and offers a more favorable metabolic profile than conventional beta-blockers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: